Burns Matteson Capital Management LLC Invests $575,000 in McKesson Corporation $MCK

Burns Matteson Capital Management LLC acquired a new stake in McKesson Corporation (NYSE:MCK) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 701 shares of the company’s stock, valued at approximately $575,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MCK. State Street Corp boosted its stake in McKesson by 0.9% during the 3rd quarter. State Street Corp now owns 5,750,519 shares of the company’s stock worth $4,447,110,000 after purchasing an additional 51,510 shares during the last quarter. Franklin Resources Inc. raised its position in shares of McKesson by 3.5% in the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company’s stock valued at $2,071,428,000 after buying an additional 90,948 shares during the last quarter. Alliancebernstein L.P. lifted its stake in shares of McKesson by 5.6% in the third quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company’s stock worth $1,850,001,000 after buying an additional 126,684 shares in the last quarter. Northern Trust Corp boosted its position in McKesson by 0.4% during the third quarter. Northern Trust Corp now owns 1,532,856 shares of the company’s stock worth $1,184,193,000 after acquiring an additional 6,613 shares during the last quarter. Finally, Boston Partners boosted its position in McKesson by 6.7% during the third quarter. Boston Partners now owns 1,330,953 shares of the company’s stock worth $1,027,569,000 after acquiring an additional 83,357 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

McKesson stock opened at $864.99 on Wednesday. The firm has a 50 day simple moving average of $908.89 and a 200-day simple moving average of $842.77. The stock has a market cap of $105.95 billion, a price-to-earnings ratio of 24.88, a price-to-earnings-growth ratio of 1.38 and a beta of 0.38. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period in the prior year, the firm posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio is currently 9.43%.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Maria Martinez sold 349 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares in the company, valued at approximately $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on MCK. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. JPMorgan Chase & Co. upped their price target on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Raymond James Financial set a $970.00 price objective on McKesson in a research report on Thursday, March 5th. Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a research note on Sunday, March 22nd. Finally, Morgan Stanley restated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.